Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Hypoxia-inducible factor 1 in autoimmune diseases.
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells.
Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study).
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Protein misfolding and clearance in demyelinating peripheral neuropathies: Therapeutic implications.
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Disruption of estrous cycle homeostasis in mice with experimental autoimmune encephalomyelitis.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
The topographical model of multiple sclerosis: A dynamic visualization of disease course.
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Perioperative management of a patient undergoing a novel mini-invasive percutaneous transcatheter left ventricular reconstruction procedure.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: No.
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Nerve pathologic features differentiate POEMS syndrome from CIDP.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
Occupational Therapy Interventions for Adults With Multiple Sclerosis.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Pages
« first
‹ previous
…
678
679
680
681
682
683
684
685
686
…
next ›
last »